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tionship between irreversible A 1 -AdoR occupancy by p-DITC-ADAC and inhibition of cAMP accumulation revealed a relatively large receptor reserve (64%) for the maximal response. In guinea pig isolated hearts, m-DITC-ADAC (5 M) prolonged the stimulus to His bundle (SH) interval by 2.1-fold; this response could be prevented by the antagonist 8-cyclopentyltheophylline (5 M). However, after the SH interval prolongation was established, extensive washout or the addition of 8-cyclopentyltheophylline had little reversal effect on the m-DITC-ADAC response. Binding of [ 3 H]CPX to the guinea pig ventricular membranes after m-DITC-ADAC treatment and washing was reduced by 35%. The A 1 -AdoR occupancy response relationship for m-DITC-ADAC to prolong the SH interval indicated a small (10 -20%) receptor reserve. Both p -and m-DITC-ADAC seem to be irreversible full agonists at the A 1 -AdoR and may prove to be useful probes to further investigate A 1 -AdoR structure-function relationships.
Adenosine is a ubiquitous modulator of physiological processes that acts to both increase tissue oxygen supply and reduce metabolic demand. The actions of adenosine are mediated by cell surface receptors and at least four subtypes, designated A 1 , A 2A, A 2B , and A 3 , have been identified, with each subtype mediating cellular effects by coupling to G proteins (1) (2) (3) (4) . The AdoR regulates the activity of several cellular components, including inhibition of adenylyl cyclase activity, stimulation of phospholipases A 2 and C, and guanylyl cyclase, and regulates the ion permeability of calcium and potassium channels (2) (3) (4) . The A 2 -AdoRs, on the other hand, mediate stimulation of adenylyl cyclase activity (1, 2) . Although less is known about the A 3 -AdoR, it has been reported that this AdoR subtype mediates an inhibition of adenylyl cyclase and a stimulation of phospholipase C, resulting in an elevation of inositol phosphates (5, 6) . The characterization, function, and regulation of the AdoRs have been greatly facilitated by the development of potent and selective agonists and antagonists (1, 7, 8) .
Chemoreactive ligands are useful pharmacological probes in structure and function studies of receptors (9) . These ligands are usually composed of two components: a pharmacophore and a reactive moiety. The pharmacophore is usually derived from known agonists or antagonists, which provide affinity and selectivity for the receptor. The reactive moiety allows covalent incorporation of the ligand into the receptor, which prevents ligand dissociation (9) . These ligands have been used in a variety of studies, including determination of receptor reserve (10, 11) , receptor subtype discrimination (12, 13) , basal receptor turnover (14, 15) , and ligand binding site mapping (16, 17) .
Jacobson et al. (18) have synthesized a series of potential irreversible ligands for the adenosine receptor by modifying the high affinity agonist pharmacophore ADAC with substituents containing reactive electrophilic groups. Coupling of ADAC with 1,3-or 1,4-phenylene DITC produced p-and m-DITC-ADAC, which were shown by radioligand binding assays to be relatively selective and irreversible ligands for the rat brain A 1 -AdoR. In the current study, the agonist properties of p-and m-DITC-ADAC for the A 1 -AdoR were determined and contrasted with an established agonist. In addition, as potential irreversible agonists, under the appropriate experimental conditions these compounds occupy and activate a fixed fraction of the total receptor population. From the fixed fraction receptor occupancy-response relationship, the receptor reserve for the irreversible agonist can be determined. Toward these goals, the p-and m-DITC-ADAC binding properties and cAMP accumulation effects mediated by the A 1 -AdoR in DDT cells and the A 1 -AdoRinduced slowing of AV nodal conduction in the guinea pig isolated heart were investigated.
Experimental Procedures
Materials. (18) . The structures of these compounds are shown in Fig. 1 . Stock solutions of p-and m-DITC-ADAC, CPA, and CPT (10 mM) were prepared in dimethylsulfoxide, stored at Ϫ20°, and diluted with incubation buffer immediately before use. Stock solutions of NECA were made in 5 mM HCl, stored at Ϫ20°, and diluted with buffer before use.
Cell culture. DDT cells were grown as monolayers in 150-mm culture dishes with Dulbecco's modified Eagle's medium containing 5% fetal bovine serum, 100 units/ml penicillin G, 0.1 mg/ml streptomycin, and 2.5 g/ml amphotericin B in a water-humidified 5% CO 2 /95% air mixture at 37°. Cells were seeded at 0.2-1 ϫ 10 4 cells/cm 2 and subcultured twice weekly after detachment using 1 mM EDTA in HBSS without the divalent cations. Experiments were performed on cells 1 day before confluency unless otherwise indicated.
Determination of cAMP accumulation. DDT cells were detached using a cell lifter in 5 ml of HBSS and pelleted by centrifugation at 500 ϫ g for 5 min. Cells (0.2-0.3 mg of protein) were then incubated in microfuge tubes with 500 l of HBSS containing 100 M rolipram and the indicated concentrations of drugs. Incubations were performed at 37°for 10 min unless otherwise indicated. Reactions were terminated by placing the tubes in a boiling water bath for 5 min. After cooling to room temperature, the tubes were centrifuged for 2 min at 10,000 ϫ g, and the supernatants were saved for assays.
The cAMP content was determined by a modified competitive protein binding assay (19) . Briefly, an aliquot of the supernatant (50 l) was incubated in a total volume of 0.2 ml of 25 mM Tris⅐HCl buffer, pH 7.0, containing 8 mM theophylline, 0.8 pmol of [ 3 H]cAMP, and 24 g of bovine heart cAMP-dependent protein kinase at 4°for 60 min. At the end of the incubation, 70 l of 50% (v/v) hydroxyapatite/water suspension was added, followed by 4 ml of ice-cold 10 mM Tris⅐HCl buffer, pH 7.0. The suspension was then filtered through Whatman GF/B glass-fiber filters under reduced pressure using a Brandel Cell Harvester (Montreal, Quebec, Canada); the filters were washed twice with 3 ml of ice-cold 10 mM Tris⅐HCl, pH 7.0, and placed in a scintillation vial with 3 ml of Scinti-Verse BD. The radioactivity retained on the filters was determined in a liquid scintillation counter. The amount of cAMP in the assay was calculated from a standard curve determined with known concentrations of unlabeled cAMP.
Membrane preparation. Monolayers of DDT cells were washed two times with 10 ml of ice-cold HBSS, and the cells were scraped free in 5 ml of ice-cold 50 mM Tris⅐HCl buffer, pH 7.4, containing 5 mM MgCl 2 . The suspensions were then homogenized with a SDT-100EN homogenizer (Tekmar, Cincinnati, OH) at the lowest speed for 5 sec, diluted to 35 ml with homogenization buffer, and centrifuged at 27,000 ϫ g for 10 min in a Sorvall RC-5B centrifuge. The supernatants were discarded, and the pellets were washed two additional times by resuspension and centrifugation as above. The final pellets were resuspended in one volume of homogenization buffer for assays.
Guinea pig ventricular membranes were prepared as previously described (20) . Briefly, guinea pig hearts were perfused for 10 min with oxygenated Krebs-Henseleit solution to remove blood. Ventricles were then isolated, minced, and homogenized in 10 volumes of ice-cold 50 mM Tris⅐HCl buffer, pH 7.4. The homogenate was centrifuged at 48,000 ϫ g for 15 min to pellet the membranes. The pellet was resuspended in 30 ml of homogenization buffer and centrifuged as above, and the membranes were washed twice more by resuspension and centrifugation. The final pellet was resuspended in one volume of appropriate buffer for assays. The protein content of membrane preparations was determine according to Bradford (21) method, with a BioRad (Richmond, CA) assay and bovine serum albumin as standard.
Radioligand binding assays.. A 1 -AdoRs in DDT cell and cardiac membranes were determined according to the specific binding of [ 3 H]CPX as described by Scammells et al. (22) and Belardinelli et al. (20) . Briefly, membrane protein (0.1-0.2 mg) was incubated in a volume of 0.25 ml containing 50 mM Tris⅐HCl buffer, pH 7.4, 5 mM MgCl 2 , 2 units/ml adenosine deaminase, and 0.06-4 nM [ 3 H]CPX for 90 min at 25°. Nonspecific binding was determined using CPX (10 M) to displace the specific binding. At the end of the incubation, the suspensions were diluted with 3 ml of ice-cold incubation buffer, and the membranes with bound radioligand were collected by filtration through GF/B glass-fiber filters under reduced pressure. The filters were washed with an additional 6 ml of ice-cold buffer and placed in scintillation vials with 3 ml of Scinti-Verse BD, and the radioactivity was determined using a liquid scintillation counter. Specific The functional A 1 response in guinea pig isolated hearts. Guinea pig isolated hearts were perfused at a constant flow (10 ml/min) and instruments for measurement of AV nodal conduction time were attached as described previously (23) . The hearts were perfused with oxygenated Krebs-Henseleit solution (pH 7.4, 35°) containing the drugs as indicated. The atrium of the heart was stimulated at a constant cycle length of 300 msec throughout the experiment. The A 1 -AdoR-mediated prolongation of the SH interval, an index of the delay in AV nodal conduction caused by adenosine and other compounds, was measured on a beat-by-beat throughout the experiment.
Data analysis. The receptor concentrations (B max ) and dissociation constants (K d ) for the radiolabeled ligands were determined from nonlinear regression analysis of Rosenthal (24) plots. The concentration of drugs that inhibited cAMP accumulation by 50% (IC 50 ) was determined using a concentration-effect analysis with a nonlinear regression algorithm (Marquardt-Levenberg). The occupancyresponse relationship was fitted to a sigmoid equation using nonlinear regression (Table Curve V2.0; Jandel Scientific, San Rafel, CA) to estimate the receptor reserve for the maximal response defined as Ͼ90%. Statistical analysis of the experimental data was performed using the Student's t test and were considered significant if p Ͻ 0.05. To examine the reversibility of the p-DITC-ADAC and CPA effects in DDT cells, the selective A 1 antagonist CPX was used to attempt to displace the agonists bound at the A 1 -AdoR. As shown in Fig. 3 , (Ϫ)-isoproterenol (1 M) increased cAMP accumulation in a time-dependent manner from 20 (basal) to 605 pmol/mg of protein over a 12-min incubation period. This increase of cAMP accumulation was attenuated by 70% and 80% after a 5-min incubation in the presence of 1 M p-DITC-ADAC or 1 M CPA, respectively, and by 80% and 81%, respectively, after 12 min of incubation. When CPX (1 M) was added after incubation with p-DITC-ADAC (1 M) and (Ϫ)-isoproterenol (1 M), no reversal of the p-DITC-ADAC-mediated attenuation of (Ϫ)-isoproterenol-stimulated cAMP accumulation was observed. This demonstrated that once receptor activation had been established, the inhibition by p-DITC-ADAC was insensitive to CPX, a finding consistent with an irreversible interaction between p-DITC-ADAC and the A 1 -AdoR. In contrast, the addition of CPX after a 4-min incubation with (Ϫ)-isoproterenol and CPA resulted in a time-dependent increase in cAMP accumulation such that at the end of the 12-min incubation period, the attenuation of cAMP accumulation by CPA was reduced from 81% in the absence of CPX to 36% in its presence. This indicates that CPA-mediated attenuation of cAMP accumulation and the interaction of CPA with the A 1 -AdoR are reversible.
Results

Effect of p-and m-DITC-ADAC
To further investigate the interaction of p-DITC-ADAC with the A 1 -AdoR, radioligand binding experiments were At receptor occupancy levels of 16%, 29%, 34%, and 46%, there was a 32%, 58%, 73%, and 78% inhibition of (Ϫ)-isoproterenol-stimulated cAMP accumulation, respectively (Fig. 6) . Using nonlinear regression analysis, the calculated receptor reserve for p-DITC-ADAC in DDT cells was ϳ64% because the maximal inhibition of (Ϫ)-isoproterenol-stimulated cAMP accumulation (defined as Ͼ90%) was obtained at 36% receptor occupancy. This level of receptor reserve for p-DITC-ADAC is based on the assumption that all A 1 -AdoRs that were measured are coupled to the inhibition of cAMP accumulation.
Effect of m-DITC-ADAC on A 1 -AdoR-mediated functional response in guinea pig isolated hearts. As shown in Fig. 7A , CPA (50 nM) prolonged the SH interval of isolated guinea pig hearts from 35 to 70 msec. This effect of CPA was rapidly and nearly completely reversed on washout or the addition of the antagonist CPT (5 M). Similar to CPA, m-DITC-ADAC (5 M) prolonged the SH interval from 37 to 79 msec, which was sustained during a 40-min washout (Fig.  7B) . Furthermore, perfusion of the heart with a supramaximal concentration of CPT (5 M) caused only a small attenuation of the m-DITC-ADAC effect. In contrast, when the hearts were pretreated with the antagonist CPT (5 M) before exposure to m-DITC-ADAC, the negative dromotropic (Fig. 8) . On washout of CPT but still in the presence of 5 M m-DITC-ADAC, the SH interval rapidly lengthened from 40 to 82 msec and remained prolonged during a subsequent 45-min washout period. Thus, the functional effect of m-DITC-ADAC could be prevented by preincubation with the antagonist CPT, but once the effect was established, it persisted and could not be reversed.
The effect of m-DITC-ADAC on [ 3 H]CPX binding to the A 1 -AdoR in guinea pig ventricle membranes is illustrated in Fig. 9 . In control membranes, maximal Several criteria using radioligand binding assays are commonly used to determine whether a chemoreactive ligand binds in an irreversible manner to a receptor: (i) a decrease in radioligand binding capacity, (ii) lack of receptor recovery after extensive washing to remove the free chemoreactive ligand, and (iii) a time-dependent loss of the receptor (9). In and guinea pig isolated heart were time dependent and not reversed by extensive washing to remove the free ligand. These findings are consistent with the two agonists binding to the A 1 -AdoR in an irreversible manner and confirm the findings with these two compounds as reported by Jacobson et al. (18) , who used rat brain membranes as the receptor source. Because the preincubation protocol involved intact DDT cells, the p-and m-DITC-ADAC-induced A 1 -AdoR decreases could be explained by a combination of receptor acylation and agonist-induced receptor down-regulation. However, the contribution of agonist-induced down-regulation is likely to be minor because pretreatment of the cells with the higher potency reversible agonist CPA for the same time period (1 hr) did not result in a decrease in specific [ 3 H]CPX binding to the A 1 -AdoR. Furthermore, the half-life of agonistinduced down-regulation of the A 1 -AdoR in DDT cells has been reported to be ϳ8 hr (25) . This relatively slow rate of agonist-induced down-regulation suggests that only a small fraction of the receptors would have been lost during the 1-hr preincubation protocol of the current study.
The apparent irreversible binding of p-and m-DITC-ADAC to the A 1 -AdoR is likely due to an addition reaction leading to covalent bond formation between the electrophilic isothiocyanate moiety of the compounds and a nucleophilic amino acid located within or in close proximity to the ligand binding site of the receptor. Whether both p-and m-isomers of DITC-ADAC react with the same or different nucleophiles in the A 1 -AdoR remains to be determined.
In several experiments, the interaction of p-DITC-ADAC with the A 2A -AdoR in PC12 cells was investigated using [ (Fig. 3) . As expected, when CPX was added after a 4-min incubation with CPA alone, the inhibition of cAMP accumulation was largely reversed, which is consistent with CPA being a reversible A 1 -AdoR agonist. Similar to the effects in DDT cells, the m-DITC-ADAC-induced prolongation of the SH interval in the guinea pig isolated heart, an A 1 -AdoR-mediated response (4), was not reversed by the addition of an excess of the antagonist CPT or by extensive washout of m-DITC-ADAC (Fig. 7 ). This contrasts with the predicable behavior of the reversible agonist CPA; that is, the CPA-induced prolongation of the SH interval was completely reversed by washout of this agonist or addition of the antagonist CPT. Thus, the antagonist-insensitive effects of p-and m-DITC-ADAC to mediate cell and tissue responses are consistent with the radioligand binding data indicating these compounds bind irreversibly to the A 1 -AdoR. Irreversible activation of the A 1 -AdoR by m-DITC-ADAC would explain the sustained decrease in heart rate caused by this agonist in the rabbit isolated heart (28). Other irreversible agonists for AdoRs have been reported. Lohse et al. (29) showed that the photoaffinity ligand (R)-2-azido-N 6 -p-hydroxyphenylisopropyladenosine produced irreversible activation of the A 1 -AdoR in fat cells. This compound, however, caused an irreversible blockade of the A 2 -AdoR in human platelets (30) . More recently, Niiya et al. (31) studied an arylisothiocyanate derivative of a functionalized congener of adenosine, 2-[(2-aminoethyl-aminocarbonylethyl)phenylethylamino]-5Ј-N-ethylcarboxamidoadenosine, and this compound produced sustained, antagonist insensitive coronary vasodilation in the guinea pig heart, indicating irreversible activation of the A 2A -AdoR. It is not known whether this latter compound acts as an irreversible agonist at the A 1 -AdoR.
Receptor reserve for p-and m-DITC-ADAC. The concept of receptor reserve, in which a maximal response can be achieved at submaximal receptor occupancy, was introduced by Stephenson in 1956 (32) . Typically, the receptor reserve is estimated with the use of irreversible antagonists (9-11, 33, 34) . The persistent activation of the A 1 -AdoR by p-and m-DITC-ADAC allowed us to determine the relationship between fixed fraction receptor occupancy and response and hence the receptor reserve for these irreversible agonists. In DDT cells, the maximal inhibition of (Ϫ)-isoproterenol-stimulated cAMP accumulation was achieved when ϳ36% of the A 1 -AdoRs were irreversibly activated by p-DITC-ADAC (Fig.  6 ), which indicates that there is a ϳ64% receptor reserve for the maximal response produced by p-DITC-ADAC in DDT cells. The presence of a relatively high receptor reserve for the A 1 -AdoR-mediated inhibition of isoproterenol-stimulated cAMP accumulation in fat cells has also been reported for a photoaffinity A 1 adenosine agonist (29) . It should be pointed out that the magnitude of the receptor reserve, as determined in the current study, may be affected by several celldependent factors, including the presence of internalized receptors and the possibility that not all of the receptors measured are coupled to G proteins. Furthermore, in addition to the inhibition of cAMP accumulation, the A 1 -AdoR in DDT cells has been shown to mediate inositol phosphate accumulation (35) . Thus, the receptor reserve for an agonist eliciting more than one response in a cell by the same receptor may be different, as has been shown for the muscarinic receptor in chick heart cells (36) .
In contrast to DDT cells, the occupancy-response relationship for m-DITC-ADAC-mediated prolongation of the SH interval showed that 80-90% of the A 1 -AdoRs must be irreversibly activated to achieve the maximal response, indicating a 10-20% receptor reserve (Fig. 10) . This small receptor reserve is similar to that determined, with an irreversible antagonist, for A 1 -AdoR activation of an inwardly rectifying K ϩ current by adenosine in guinea pig atrial myocytes (37) . On the other hand, Dennis et al. (11) , using an irreversible antagonist in combination with the method developed by Furchgott (38) , calculated a 54% receptor reserve for the maximal CPA-mediated increase in the SH interval of the guinea pig heart. Because the receptor reserve is dependent on both the tissue and agonist (36) , the difference in receptor reserve for m-DITC-ADAC and CPA to maximally increase the SH interval may in part be due to CPA having a higher intrinsic efficacy than m-DITC-ADAC. Alternatively, the difference in receptor reserve for these two agonists may be related to CPA being a reversible agonist, whereas m-DITC-ADAC irreversibly activates the A 1 -AdoR.
In summary, the data from the current study show that pand m-DITC-ADAC are relatively potent, full agonists at the A 1 -AdoR. The irreversible binding and persistent agonist properties of these compounds suggest that they or related derivatives may be useful probes for further studies on the mechanism of receptor activation and effector coupling, desensitization and, in radiolabeled form, for elucidation of the structure of the A 1 -AdoR agonist binding site.
